The US FDA's proposed reorganization of the Office of the Commissioner will elevate the agency’s medical product centers to report directly to Commissioner Scott Gottlieb, as part of a “flattening” of the org chart that announced in an all-FDA email to staff on July 19.
The six center directors – including Center for Drug Evaluation & Research Janet Woodcock – will report directly to Gottlieb,...






